MDT
87.32 USD
-0.81%
Today
-0.81%
1D
Market is closed
Sun
Closed
Mon
3:00 AM ~ 12:00 PM
Tue
12:00 AM ~ 12:00 PM
Wed
12:00 AM ~ 12:00 PM
Thu
12:00 AM ~ 12:00 PM
Fri
12:00 AM ~ 11:00 PM
Sat
Closed
Information
Name
Medtronic Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0191%
Overnight Fees Sell
0.0024%
Market Cap
110.77B
Avg Daily Volume
7.67M
52 Week High
106.33 USD
52 Week Low
79.55 USD
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01910% | $(0.191) |
| SELLS | 0.00240% | $0.024 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.
Top News
Medtronic Granted FDA Clearance For Stealth AXiS Surgical System In Cranial And ENT Procedures
tradingview.com
2w ago
Medtronic Inks Distribution Agreement With Merit Medical Systems To Offer FDA-approved ViaVerte
tradingview.com
2w ago
AMC.Entertainment
+0.76%
AeroVironment
+1.88%
ConocoPhil
-0.24%
Cencora
-0.47%
Chevron
-0.53%
DollarTree
-2.91%
FuelCell
+1.69%
Freeport_Mcmoran
+2.43%
GE.Vernova
+2.48%
Insmed
-3.03%
Cheniere
-0.08%
MongoDB
-1.17%
Medtronic
-0.81%
NewmontM
+2.35%
Occidental
+0.00%
PG&E
-0.54%
Palantir
-1.55%
SouthernCopper
+2.32%
Synopsys
-2.97%
Stryker
+0.14%
Target
-1.54%
TripAdvisor
-4.89%
TeslaMotor
+1.03%
UnitedCon
-1.32%
Viatris
-0.88%
Valvoline
-2.63%
ExxonMobil
-1.24%
BUZZ-U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
reuters.com
2w ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
